Advanced search
Publication Cover
Journal of Chemotherapy Volume 18, 2006 - Issue 6
Submit an article Journal homepage
38
Views
23
CrossRef citations to date
0
Altmetric
Antimicrobial Chemotherapy

Moxifloxacin and Gatifloxacin in an Acid Model of Persistent Mycobacterium tuberculosis

G. Kubendiran
,
C.N. Paramasivan
,
S. Sulochana
&
D.A. Mitchison
Pages 617-623 | Published online: 18 Jul 2013

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

H. Simon Schaaf, Stephanie Thee, Louvina van der Laan, Anneke C. Hesseling & Anthony J. Garcia-Prats. (2016) Adverse effects of oral second-line antituberculosis drugs in children. Expert Opinion on Drug Safety 15:10, pages 1369-1381.
Read now
S. Sulochana, D.A. Mitchison, G. Kubendiren, P. Venkatesan & C.N. Paramasivan. (2009) Bactericidal Activity of Moxifloxacin on Exponential and Stationary Phase Cultures of Mycobacterium tuberculosis . Journal of Chemotherapy 21:2, pages 127-134.
Read now

Articles from other publishers (21)

Devyani Deshpande, Gesham Magombedze, Shashikant Srivastava, Paula Bendet, Pooi S Lee, Kayle N Cirrincione, Katherine R Martin, Keertan Dheda & Tawanda Gumbo. (2019) Once-a-week tigecycline for the treatment of drug-resistant TB. Journal of Antimicrobial Chemotherapy 74:6, pages 1607-1617.
Crossref
Devyani Deshpande, Shashikant Srivastava, Paula Bendet, Katherine R. Martin, Kayle N. Cirrincione, Pooi S. Lee, Jotam G. Pasipanodya, Keertan Dheda & Tawanda Gumbo. (2018) Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis. Antimicrobial Agents and Chemotherapy 62:2.
Crossref
Devyani DeshpandeShashikant SrivastavaMoti ChapagainGesham Magombedze, Katherine R. MartinKayle N. Cirrincione, Pooi S. Lee, Thearith Koeuth, Keertan Dheda & Tawanda Gumbo. (2017) Ceftazidime-avibactam has potent sterilizing activity against highly drug-resistant tuberculosis. Science Advances 3:8.
Crossref
N Tamilselvan, Ernest David, Dharumadurai Dhanasekaran & Kumar Saurav. 2015. Antimicrobials. Antimicrobials 435 456 .
Joseph Buensalido, Carmen DeMarco & Stephen Lerner. 2015. Practical Handbook of Microbiology, Third Edition. Practical Handbook of Microbiology, Third Edition 153 182 .
Tawanda Gumbo, Anne J. Lenaerts, Debra Hanna, Klaus Romero & Eric Nuermberger. (2015) Nonclinical Models for Antituberculosis Drug Development: A Landscape Analysis. Journal of Infectious Diseases 211:suppl 3, pages S83-S95.
Crossref
S. Thee, A.J. Garcia-Prats, P.R. Donald, A.C. Hesseling & H.S. Schaaf. (2015) Fluoroquinolones for the treatment of tuberculosis in children. Tuberculosis 95:3, pages 229-245.
Crossref
N. Veziris. (2013) Les nouveaux antituberculeux (2) : nouvelles molécules. Journal des Anti-infectieux 15:3, pages 133-140.
Crossref
Mohideen S. Jawahar, Vaithilingam V. Banurekha, Chinnampedu N. Paramasivan, Fathima Rahman, Rajeswari Ramachandran, Perumal Venkatesan, Rani Balasubramanian, Nagamiah Selvakumar, Chinnaiyan Ponnuraja, Allaudeen S. Iliayas, Navaneethapandian P. Gangadevi, Balambal Raman, Dhanaraj Baskaran, Santhanakrishnan R. Kumar, Marimuthu M. Kumar, Victor Mohan, Sudha Ganapathy, Vanaja Kumar, Geetha Shanmugam, Niruparani Charles, Murugesan R. Sakthivel, Kannivelu Jagannath, Chockalingam Chandrasekar, Ramavaram T. Parthasarathy & Paranji R. Narayanan. (2013) Randomized Clinical Trial of Thrice-Weekly 4-Month Moxifloxacin or Gatifloxacin Containing Regimens in the Treatment of New Sputum Positive Pulmonary Tuberculosis Patients. PLoS ONE 8:7, pages e67030.
Crossref
R. Cremades, J. C. Rodriguez, E. Garcia-Pachon, A. Galiana, M. Ruiz-Garcia, P. Lopez & G. Royo. (2011) Comparison of the bactericidal activity of various fluoroquinolones against Mycobacterium tuberculosis in an in vitro experimental model. Journal of Antimicrobial Chemotherapy 66:10, pages 2281-2283.
Crossref
Mary A. De Groote, Janet C. Gilliland, Colby L. Wells, Elizabeth J. Brooks, Lisa K. Woolhiser, Veronica Gruppo, Charles A. Peloquin, Ian M. Orme & Anne J. Lenaerts. (2011) Comparative Studies Evaluating Mouse Models Used for Efficacy Testing of Experimental Drugs against Mycobacterium tuberculosis . Antimicrobial Agents and Chemotherapy 55:3, pages 1237-1247.
Crossref
Denis A. Mitchison. (2010) Activity of Pyrazinamide in the Guinea Pig Model of Tuberculosis. Antimicrobial Agents and Chemotherapy 54:12, pages 5420-5420.
Crossref
Ruiru Shi & Isamu Sugawara. (2010) Development of New Anti-tuberculosis Drug Candidates. The Tohoku Journal of Experimental Medicine 221:2, pages 97-106.
Crossref
Denis Anthony Mitchison & Kwok Chiu Chang. (2009) Experimental Models of Tuberculosis: Can We Trust the Mouse?. American Journal of Respiratory and Critical Care Medicine 180:3, pages 201-202.
Crossref
Susan E. Dorman, John L. Johnson, Stefan Goldberg, Grace Muzanye, Nesri Padayatchi, Lorna Bozeman, Charles M. Heilig, John Bernardo, Shurjeel Choudhri, Jacques H. Grosset, Elizabeth Guy, Priya Guyadeen, Maria Corazon Leus, Gina Maltas, Dick Menzies, Eric L. Nuermberger, Margarita Villarino, Andrew Vernon & Richard E. Chaisson. (2009) Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis. American Journal of Respiratory and Critical Care Medicine 180:3, pages 273-280.
Crossref
Tawanda Gumbo, Chandima S. W. Siyambalapitiyage Dona, Claudia Meek & Richard Leff. (2009) Pharmacokinetics-Pharmacodynamics of Pyrazinamide in a Novel In Vitro Model of Tuberculosis for Sterilizing Effect: a Paradigm for Faster Assessment of New Antituberculosis Drugs. Antimicrobial Agents and Chemotherapy 53:8, pages 3197-3204.
Crossref
Jossy van den Boogaard, Gibson S. Kibiki, Elton R. Kisanga, Martin J. Boeree & Rob E. Aarnoutse. (2009) New Drugs against Tuberculosis: Problems, Progress, and Evaluation of Agents in Clinical Development. Antimicrobial Agents and Chemotherapy 53:3, pages 849-862.
Crossref
S. Bonora, A. Mondo, L. Trentini, A. Calcagno, A. Lucchini & G. Di Perri. (2008) Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins. Journal of Infection 57:1, pages 78-81.
Crossref
Anne J. Lenaerts, Casey Bitting, Lisa Woolhiser, Veronica Gruppo, Karen S. Marietta, Christine M. Johnson & Ian M. Orme. (2008) Evaluation of a 2-Pyridone, KRQ-10018, against Mycobacterium tuberculosis In Vitro and In Vivo . Antimicrobial Agents and Chemotherapy 52:4, pages 1513-1515.
Crossref
Dinakaran Murugesan, Senthilkumar Palaniappan, Yogeeswari Perumal, China Arnab, Nagaraja Valakunja & Dharmarajan Sriram. (2008) Antimycobacterial and phototoxic evaluation of novel 6-fluoro/nitro-4-oxo-7-(sub)-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid. International Journal of Antimicrobial Agents 31:4, pages 337-344.
Crossref
Stephen H Gillespie. (2007) Moxifloxacin: a potential new drug for shortening treatment of pulmonary TB?. Therapy 4:6, pages 813-820.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.